Novo Nordisk to Pay $100M to Settle Securities Class Action

Novo Nordisk announces that it has reached an agreement in principle to settle the previously disclosed securities class action litigation pending in the Federal District Court of New Jersey, US.

• Under the terms of the settlement agreement, Novo Nordisk has agreed to pay $100 million, inclusive of all plaintiffs’ attorneys fees and expenses and settlement costs
  • Payment is covered by insurance
  • Payment will be made into a settlement fund and distributed among plaintiffs
• Lawsuit was filed in January 2017 on behalf of purchasers of American Depository Receipts during the class period February 3, 2015 to February 2, 2017 against Novo ...